We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan, Novartis Settle Spat Over Femara Generic

Law360 (December 2, 2008, 12:00 AM EST) -- Novartis Pharmaceutical Corp. has ended its battle with generic-drug maker Mylan Inc. over the patent for the generic version of Novartis' Femara, a drug that treats breast cancer in postmenopausal women,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.